Oxyethylammonium methylphenoxyacetate - instructions for use, dose, side effects, contraindications

Clinical and pharmacological group: & nbsp

Genotoninizing agents and adaptogens

Detoxifying agents, including antidotes

Included in the formulation

Trekresan

pills inwards

PHARMATRIX LLC Russia

АТХ:

A.13.A Tetanus preparations

Pharmacodynamics:

The drug is an adaptogen of a wide spectrum of action, stimulates production α- and γ-terferons, activates humoral and cellular immunity, enhances the phagocytic activity of macrophages. Has a pronounced antitoxic effect in case of poisoning with organic solvents, ethanol, salts of heavy metals.

The drug strengthens the body's immune system, increases endurance with physical and mental loads, reduces the effect of various toxins, increases the body's resistance to hypoxia, low and high temperatures and other unfavorable environmental factors.

Pharmacokinetics:

Not described.

Indications:

Alcohol withdrawal syndrome.
Poisoning with salts of heavy metals.
Secondary immunodeficiency, including against a background of prolonged antibiotic therapy.
To increase physical and mental performance, prevent fatigue, to increase the body's resistance various stress effects (hypoxia, overheating, hypothermia).
To improve immunity (prevention and treatment of colds, flu, ARVI and other viral and bacterial diseases).

ICD-10

I.A30-A49.A49.9 Bacterial infection, unspecified

I.B25-B34.B34.9 Viral infection, unspecified

III.D80-D89.D84.8 Other specified immunodeficiency disorders

III.D80-D89.D84.9 Immunodeficiency, unspecified

IV.E50-E64.E63 Other types of malnutrition

V.F10-F19.F10.3 Mental and behavioral disorders caused by alcohol use - withdrawal symptoms

X.J00-J06 Acute respiratory infections of the upper respiratory tract

X.J00-J06.J06.9 Acute upper respiratory tract infection, unspecified

X.J10-J18.J10 Influenza caused by an identified influenza virus

X.J10-J18.J11 Influenza, virus not identified

XVIII.R50-R69.R53 Malaise and fatigue

XIX.T51-T65.T56 Toxicity of metals

XIX.T51-T65.T56.9 Toxic effect of metal, unspecified

XIX.T66-T78.T67 Effects of high temperature and light

XIX.T66-T78.T69.9 Effect of low temperature, unspecified

XX.Y40-Y59.Y40 Antibiotics of systemic action

XXI.Z20-Z29.Z29.8 Other specified preventive measures

XXI.Z70-Z76.Z73.0 Overwork

XXI.Z70-Z76.Z73.2 Insufficient rest and relaxation

XXI.Z70-Z76.Z73.3 Stress condition, not elsewhere classified

Contraindications:

Age before 12 years.
Pregnancy and lactation.
Hypersensitivity.
Hereditary lactose intolerance.
Insufficiency of lactase or impaired absorption of glucose and galactose.

Carefully:

No data.

Pregnancy and lactation:

Category FDA not determined. Adequate and well-controlled studies in humans and animals have not been conducted. The drug is contraindicated in pregnancy and lactation. There is no information on the penetration into breast milk.

Dosing and Administration:

Orally.

For increase immunity and prevent colds adults and children over 12 years - 0.2 g per day for 7-14 days.

For the treatment of colds: 0.6 g per day on the first day, 0.2 g per day for 7 days.

When poisoning with salts of heavy metals: 0.4-0.6 g per day daily for at least 5 days.

For increase physical and mental performance and enhance the body's resistance to various stresses - on the first day of 0.6 g per day, then daily at 0.2 g per day for 7 days.

For reduction of manifestations of alcohol abstinence syndrome - 0.4-0.6 g per day daily for 5 days.

If necessary, the treatment is repeated at intervals between courses of 1-2 months.

Side effects:

Allergic reactions.

Overdose:

Not described, treatment is symptomatic.

Interaction:

Not described.

Special instructions:

Impact on the ability to drive vehicles and manage mechanisms not found.

Instructions

Oxyethylammonium methylphenoxyacetate (Oxyaethylammonii methylphenoxyacetas)